About this trial
This study aims to assess the incidence, sociodemographic and clinical characteristics, treatment response, and short-term outcomes of adult patients with catatonic syndrome in the Bilbao area (Spain). Data will be collected from January 2024 to December 2025 from all patients aged 18 years or older diagnosed with catatonia of any etiology at Basurto University Hospital who provide informed consent to participate.
Eligibility criteria
Qualifiers
Age ≥ 18 years at the time of hospital care.
Diagnosis of catatonic syndrome established according to DSM-5 criteria.
Patients attended at Basurto University Hospital in any clinical setting, including the Emergency Department or inpatient physical or psychiatric units.
Diagnosis made during the study period, from 1 January 2024 to 31 December 2025.
Disqualifiers
Refusal to participate in the study by the patient or their legal representative.
Withdrawal of informed consent at any point during the study.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Beatriz Rodriguez Cabo
Lead sponsor
University of the Basque Country (UPV/EHU)
Sponsor institution